Literature DB >> 1708784

Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.

J B Allen1, H L Wong, P M Guyre, G L Simon, S M Wahl.   

Abstract

Monocytes in the circulation of normal individuals express two receptors for the constant region of immunoglobulin, Fc gamma RI and Fc gamma RII. In contrast, we have observed that AIDS monocytes express significant levels of a third Fc gamma R, Fc gamma RIII (CD16), which is normally associated with activation or maturation of the monocyte population. By dual-fluorescence analysis using a monoclonal antibody specific for Fc gamma RIII (MAb 3G8), 38.5 +/- 3.2% of the LeuM3 (CD14)-positive monocytes in AIDS patients were CD16 positive as compared to 10.4 +/- 1.0% for healthy individuals (n = 29; P less than 0.005). Furthermore, AIDS monocytes expressed Fc gamma RIII-specific mRNA which is expressed minimally or not at all in control monocytes. As a recently identified inducer of Fc gamma RIII expression on blood monocytes, transforming growth factor-beta (TGF-beta) was found to be elevated in the serum and/or plasma of AIDS patients. Moreover, incubation of normal monocytes with AIDS serum or plasma induced CD16 expression which correlated with serum TGF-beta levels (r = 0.74, P less than 0.001) and was inhibited with a neutralizing antibody to TGF-beta. Thus, the increased CD16 expression on peripheral blood monocytes in AIDS patients may be the consequence of elevated circulating levels of the polypeptide hormone TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708784      PMCID: PMC295289          DOI: 10.1172/JCI115196

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes.

Authors:  S M Wahl; J B Allen; S Gartner; J M Orenstein; M Popovic; D E Chenoweth; L O Arthur; W L Farrar; L M Wahl
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

Authors:  J Homsy; M Meyer; M Tateno; S Clarkson; J A Levy
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

5.  Surface markers of monocyte function and activation in AIDS.

Authors:  B L Davidson; R L Kline; J Rowland; T C Quinn
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

6.  Activity of the reticuloendothelial system in diseases of altered immunity.

Authors:  N K Salky; D Mills; N R Di Luzio
Journal:  J Lab Clin Med       Date:  1965-12

7.  Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

Authors:  A Fontana; K Frei; S Bodmer; E Hofer; M H Schreier; M A Palladino; R M Zinkernagel
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

8.  TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes.

Authors:  N McCartney-Francis; D Mizel; H Wong; L Wahl; S Wahl
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

9.  Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Authors:  W E Robinson; D C Montefiori; W M Mitchell
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

10.  Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.

Authors:  S M Wahl; J B Allen; N McCartney-Francis; M C Morganti-Kossmann; T Kossmann; L Ellingsworth; U E Mai; S E Mergenhagen; J M Orenstein
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  37 in total

1.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

Review 2.  The role of transforming growth factor-beta in inflammatory processes.

Authors:  S M Wahl
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Authors:  G Fingerle-Rowson; M Angstwurm; R Andreesen; H W Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

4.  Evidence for cFMS signaling in HIV production by brain macrophages and microglia.

Authors:  Lindsey Gerngross; Tracy Fischer
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

Review 5.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood.

Authors:  Woong-Ki Kim; Xavier Alvarez; Jeanne Fisher; Benjamin Bronfin; Susan Westmoreland; JoAnne McLaurin; Kenneth Williams
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 7.  Targeting the Fc receptor in autoimmune disease.

Authors:  Xinrui Li; Robert P Kimberly
Journal:  Expert Opin Ther Targets       Date:  2014-03       Impact factor: 6.902

8.  Diurnal cycle of emission of induced volatile terpenoids by herbivore-injured cotton plant.

Authors:  J H Loughrin; A Manukian; R R Heath; T C Turlings; J H Tumlinson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

9.  Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns.

Authors:  Sigifredo Pedraza-Sánchez; Amy G Hise; Lakshmi Ramachandra; Fabian Arechavaleta-Velasco; Christopher L King
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

10.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.